Improving access to antipsychotic medications for schizophrenia in Ethiopia, Nigeria, Rwanda, and South Africa: an evidence-based global consensus.

Katharine A Smith; Spyridon Siafis; Robert A McCutcheon; Toby Pillinger; Rachel Upthegrove; James Downs; Soraya Seedat; Emma L Lawrance; Georgia Salanti; Oye Gureje; Ilina Singh; Jennifer Potts; Solomon Teferra; Claudia Sartor; Charles Mudenge; Christoph U Correll; Andrea Cipriani

doi:10.1016/s2215-0366(26)00228-2

SCHEDA SCIENTIFICA2026Altra ricerca

Improving access to antipsychotic medications for schizophrenia in Ethiopia, Nigeria, Rwanda, and South Africa: an evidence-based global consensus.

Katharine A Smith, Spyridon Siafis, Robert A McCutcheon, Toby Pillinger, Rachel Upthegrove, James Downs, Soraya Seedat, Emma L Lawrance, Georgia Salanti, Oye Gureje, Ilina Singh, Jennifer Potts, Solomon Teferra, Claudia Sartor, Charles Mudenge, Christoph U Correll, Andrea Cipriani

The lancet. Psychiatry · 2026

Psicologia clinica Psicopatologia Psicologia della salute

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansSchizophreniaAntipsychotic AgentsSouth AfricaHealth Services AccessibilityRwandaNigeriaEthiopia

Come citare questo studio

Katharine A Smith, Spyridon Siafis, Robert A McCutcheon, Toby Pillinger, Rachel Upthegrove, James Downs, Soraya Seedat, Emma L Lawrance, Georgia Salanti, Oye Gureje, Ilina Singh, Jennifer Potts, Solomon Teferra, Claudia Sartor, Charles Mudenge, Christoph U Correll, Andrea Cipriani. (2026). Improving access to antipsychotic medications for schizophrenia in Ethiopia, Nigeria, Rwanda, and South Africa: an evidence-based global consensus.. The lancet. Psychiatry. DOI: 10.1016/s2215-0366(26)00228-2

Consulta la pubblicazione originale ↗